Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Wegovy Pill
Published 4 months, 4 weeks ago
Description
In today’s Pharmaceutical Executive Daily, the FDA approves Novo Nordisk’s oral Wegovy for chronic weight management, clears Roche’s Lunsumio Velo for adults with relapsed or refractory follicular lymphoma, and Alnylam announces a $250 million investment in a new Massachusetts manufacturing facility.